When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid ...

MindGlide was 60% better than SAMSEG and 20% better than WMH-SynthSeg for locating brain plaque (or lesion) abnormalities, or for monitoring treatment effects. The results from the study show that ...

When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid plaques that are a hallmark of the disease. But the results of that ...

GALES FERRY, Conn. (WTNH) — Within the past few years, the FDA approved two groundbreaking drugs that in trials were shown to reduce brain plaque by 27% in some Alzheimer’s patients.

MindGlide was 60% better than SAMSEG and 20% better than WMH-SynthSeg for locating brain abnormalities known as plaques (or lesions) or for monitoring treatment effect. First author, Dr Philipp ...

The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the brain many years before symptoms arise can delay the onset of Alzheimer's ...